Advisor Group Holdings »

Plus Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $193 133 1.46
2024-03-31 $239 133 1.80
2023-12-31 $232 133 1.74
2023-09-30 $177 133 1.34
2023-06-30 $267 133 2.02

More positions owned by Advisor Group Holdings

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Advisor Group Holdings

Top funds holding Plus Therapeutics

AIGH Capital Management
Geode Capital Management
Ashton Thomas Private Wealth
BlackRock
Advisor Group Holdings
Jpmorgan Chase & Co
Bank of America Corporation
Group One Trading

View all funds holding Plus Therapeutics